Virtual Medicinal Product (VMP) - Ibritumomab tiuxetan 3.2mg/2ml kit for radiopharmaceutical preparation
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Ibritumomab tiuxetan 3.2mg/2ml kit for radiopharmaceutical preparation | Start Date 08-06-2021 | End Date |
| Abbreviated Name | Abbreviated Name Ibritumomab tiuxetan 3.2mg/2ml | Start Date 08-06-2021 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2
- UDFS UOM
- ml
- Unit Dose UOM
- kit
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Kit for radiopharmaceutical preparation
- Ontology Form/Route
- solutioninfusion.intravenous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- V10XX02
| Code | Start Date | End Date |
|---|---|---|
| 39804211000001105 | 08-06-2021 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Ibritumomab tiuxetan | Based on Ingredient Substance | 1.6 mg | 1 ml |
Name
Ibritumomab tiuxetan
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1.6
Strength and UOM (Dmr)
1
Parent Products
-
VTMIbritumomab tiuxetan
-
VMP(Current) Ibritumomab tiuxetan 3.2mg/2ml kit f...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 kit |